CaMKII Inhibition is a Novel Therapeutic Strategy to Prevent Diabetic Cardiomyopathy

Increasing prevalence of diabetes mellitus worldwide has pushed the complex disease state to the foreground of biomedical research, especially concerning its multifaceted impacts on the cardiovascular system. Current therapies for diabetic cardiomyopathy have had a positive impact, but with diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Veitch, Christopher R., Power, Amelia S., Erickson, Jeffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350113/
https://www.ncbi.nlm.nih.gov/pubmed/34381362
http://dx.doi.org/10.3389/fphar.2021.695401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350113/
https://www.ncbi.nlm.nih.gov/pubmed/34381362
http://dx.doi.org/10.3389/fphar.2021.695401

Ejemplares similares